Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.

导出 OA

翻译打印收藏纠错

作者： Sylvain,Ladoire ^[1] ; Emilie,Rederstorff ^[2] ; Vincent,Goussot ^[3] ; Sophie,Parnalland ^[2] ; Nathalie,Briot ^[4] ; Elise,Ballot ^[5] ; Caroline,Truntzer ^[5] ; Siavoshe,Ayati ^[6] ; Leila,Bengrine-Lefevre ^[6] ; Nathalie,Bremaud ^[6] ; Bruno,Coudert ^[6] ; Isabelle,Desmoulins ^[6] ; Laure,Favier ^[6] ; Cléa,Fraisse ^[6] ; Jean-David,Fumet ^[6] ; Audrey,Hennequin ^[6] ; Alice,Hervieu ^[6] ; Silvia,Ilie ^[6] ; Courèche,Kaderbhai ^[6] ; Aurélie,Lagrange ^[6] ; Nils,Martin ^[6] ; Irina,Mazilu ^[6] ; Didier,Mayeur ^[6] ; Rémi,Palmier ^[6] ; Anne-Laure,Simonet-Lamm ^[6] ; Julie,Vincent ^[6] ; Sylvie,Zanetta ^[6] ; Laurent,Arnould ^[7] ; Charles,Coutant ^[8] ; Aurélie,Bertaut ^[4] ; François,Ghiringhelli ^[9]

作者单位： Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France; Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; University of Burgundy-Franche Comté, France. Electronic address: sladoire@cgfl.fr. ^[1] Clinical Research Center (CRC), Centre Georges François Leclerc, Dijon, France. ^[2] Department of Pathology and Tumor Biology, Centre Georges François Leclerc, Dijon, France. ^[3] Methodology and Biostatistics Unit, Centre Georges François Leclerc, Dijon, France. ^[4] Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Bioinformatic Core Facility Georges-François Leclerc Cancer Center, Dijon, France. ^[5] Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France. ^[6] Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Department of Pathology and Tumor Biology, Centre Georges François Leclerc, Dijon, France. ^[7] University of Burgundy-Franche Comté, France; Department of Oncologic Surgery, Centre Georges François Leclerc, Dijon, France. ^[8] Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France; Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; University of Burgundy-Franche Comté, France. ^[9]

关键词 Antibody COVID-19 Cancer center Cancer patients Cross sectional study Health care workers SARS-CoV-2 Serology Seroprevalence

主题词横断面研究(Cross-Sectional Studies);卫生人员(Health Personnel);人类(Humans);肿瘤(Neoplasms);疾病大流行(Pandemics);血清流行病学研究(Seroepidemiologic Studies)

DOI 10.1016/j.ejca.2022.01.005

PMID 35189537

发布时间 2022-12-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交